These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 19681903)
1. Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung. Shimada Y; Ishii G; Nagai K; Atsumi N; Fujii S; Yamada A; Yamane Y; Hishida T; Nishimura M; Yoshida J; Ikeda N; Ochiai A Cancer Sci; 2009 Nov; 100(11):2054-9. PubMed ID: 19681903 [TBL] [Abstract][Full Text] [Related]
2. Cancer-initiating cell marker-positive cells generate metastatic tumors that recapitulate the histology of the primary tumors. Nishijima N; Ishii G; Nagai K; Atsumi N; Aokage K; Tokunaga Y; Ichinokawa H; Ohe Y; Ochiai A Pathol Int; 2013 Feb; 63(2):94-101. PubMed ID: 23464966 [TBL] [Abstract][Full Text] [Related]
3. Co-expression of podoplanin and fibroblast growth factor 1 predicts poor prognosis in patients with lung squamous cell carcinoma. Li J; Chen H; Li X; Wang L; Gao A; Zhang P; Lin W; Gao W; Yang D; Guo X; Liu J; Dang Q; Sun Y Mol Med Rep; 2017 Aug; 16(2):1643-1652. PubMed ID: 28656229 [TBL] [Abstract][Full Text] [Related]
4. Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype. Ono S; Ishii G; Nagai K; Takuwa T; Yoshida J; Nishimura M; Hishida T; Aokage K; Fujii S; Ikeda N; Ochiai A Chest; 2013 Apr; 143(4):963-970. PubMed ID: 23081722 [TBL] [Abstract][Full Text] [Related]
5. High podoplanin expression in cancer cells predicts lower incidence of nodal metastasis in patients with lung squamous cell carcinoma. Suzuki H; Onimaru M; Koga T; Takeshita M; Yano T; Maehara Y; Nakamura S; Sueishi K Pathol Res Pract; 2011 Feb; 207(2):111-5. PubMed ID: 21194851 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of CD44v6, p63, podoplanin and MMP-9 in oral squamous cell carcinomas. Monteiro LS; Delgado ML; Ricardo S; do Amaral B; Salazar F; Pacheco JJ; Lopes CA; Bousbaa H; Warnakulasuryia S Oral Dis; 2016 May; 22(4):303-12. PubMed ID: 26788715 [TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma. Matsuwaki R; Ishii G; Zenke Y; Neri S; Aokage K; Hishida T; Yoshida J; Fujii S; Kondo H; Goya T; Nagai K; Ochiai A Cancer Sci; 2014 Jul; 105(7):905-11. PubMed ID: 24814677 [TBL] [Abstract][Full Text] [Related]
8. Podoplanin expression is correlated with the prognosis of lung squamous cell carcinoma. Ikoma Y; Kijima H; Masuda R; Tanaka M; Inokuchi S; Iwazaki M Biomed Res; 2015; 36(6):393-402. PubMed ID: 26700593 [TBL] [Abstract][Full Text] [Related]
9. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases. Buonaccorsi JN; Plaza JA Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung. Taira T; Ishii G; Nagai K; Yoh K; Takahashi Y; Matsumura Y; Kojima M; Ohmatsu H; Goto K; Niho S; Takashima H; Inoue H; Ohe Y; Ochiai A Lung Cancer; 2012 Jun; 76(3):423-30. PubMed ID: 22153829 [TBL] [Abstract][Full Text] [Related]
12. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples. Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015 [TBL] [Abstract][Full Text] [Related]
13. Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies. Ito T; Ishii G; Nagai K; Nagano T; Kojika M; Murata Y; Atsumi N; Nishiwaki Y; Miyazaki E; Kumamoto T; Ochiai A Lung Cancer; 2009 Mar; 63(3):418-24. PubMed ID: 18657337 [TBL] [Abstract][Full Text] [Related]
14. Role of fine needle aspiration cytology, cell block preparation and CD63, P63 and CD56 immunostaining in classifying the specific tumor type of the lung. Kim DH; Kwon MS Acta Cytol; 2010; 54(1):55-9. PubMed ID: 20306989 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma. Ma W; Wang K; Yang S; Wang J; Tan B; Bai B; Wang N; Jia Y; Jia M; Cheng Y Int J Clin Exp Pathol; 2014; 7(5):2361-71. PubMed ID: 24966946 [TBL] [Abstract][Full Text] [Related]
17. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. Plaza JA; Ortega PF; Stockman DL; Suster S J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670 [TBL] [Abstract][Full Text] [Related]
18. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival. de Vicente JC; Santamarta TR; Rodrigo JP; García-Pedrero JM; Allonca E; Blanco-Lorenzo V Virchows Arch; 2015 May; 466(5):549-58. PubMed ID: 25726183 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma. Cohen ER; Reis IM; Gomez C; Pereira L; Freiser ME; Hoosien G; Franzmann EJ Otolaryngol Head Neck Surg; 2017 Aug; 157(2):239-251. PubMed ID: 28397583 [TBL] [Abstract][Full Text] [Related]